肾透明细胞癌患者血清中miR-21的表达及其临床意义
2016-01-11管金,哈木拉提·吐送,王文光等
肾透明细胞癌患者血清中miR-21的表达及其临床意义
管金, 哈木拉提·吐送, 王文光, 拜合提亚·阿扎提, 木拉提·热夏提, 安恒庆, 王玉杰
(新疆医科大学第一附属医院泌尿中心, 乌鲁木齐830054)
摘要:目的探讨肾癌患者与健康人血清中miR-21的表达差异及其切除肿瘤组织后血清中的表达变化,为后期深入性研究奠定理论基础。 方法收集新疆医科大学第一附属医院泌尿外科新诊断肾癌患者30例术前血清样本(cRCC组),并于术后1个月收集其血清,另选择30例健康志愿者血清作为对照组,采用实时荧光定量PCR技术检测cRCC组术前、术后和对照组血清中miR-21的表达。结果cRCC组术前、术后及对照组血清中miR-21的表达水平差异有统计学意义(Kruskal-wallis H秩和检验,H≈χ2,P=0.001),cRCC组术前血清中miR-21表达水平是对照组的12.99倍(Z=-3.252,P=0.001),术后的表达水平是对照组的1.03倍(Z=-0.103,P=0.918),cRCC组术后血清中miR-21表达水平较术前明显下降(Z=-3.349,P=0.001)。 结论肾癌患者血清中miR-21明显高表达,在切除肿瘤组织后其表达水平明显下降,提示其与肾肿瘤密切相关,是肾癌潜在分子标记物。
关键词:血清microRNAs; 肾癌; miR-21; 分子标记物
中图分类号:R737.11文献标识码:A
doi:10.3969/j.issn.1009-5551.2015.05.005
[收稿日期:2015-02-28]
The changes of expression levels of miR-21 in the serum of patients
with renal cell carcinoma
GUAN Jin, Hamulati Tusong, WANG Wenguang, Baihetiya Azhati, Mulati Rexiat,
AN Hengqing, WANG Yujie
(DepartmentofUrology,TheFirstAffiliatedHospitalofXinjiangMedicalUniversity,
Urumqi830054,China)
Abstract:ObjectiveTo investigate the expression levels of miR-21 in the serum of patients with renal cell carcinoma, and to lay a theoretical foundation for the in-depth study in the future. Methods30 serum samples of patients with renal cell carcinoma was collected before surgery, and the blood serum samples were collected again after surgery a month later. Moreover, the study includes 30 healthy controls. The expression levels of miR-21 in the serum of samples from three groups were compared by using the real-time PCR. ResultsmiR-21 expression in serum have statistical significance amang renal clear cell carcinoma, post-operation and normal group (Kruskal-wallis H rank sum test H, H≈χ2=14.882, P=0.001). compared with the normal group, miR-21 expression in renal cell carcinoma is 12.99 times (Z=-3.252, P=0.001), and in post-operation is 1.03 times (Z=-0.103 P=0.918). ConclusionThe expression levels of miR-21 in the serum in patients with renal cell carcinoma is significantly increased, while it decreased significantly after resection. The outcome suggests that the expression levels of miR-21 in the serum is closely related with renal cell carcinoma. Therefore, miR-21 can be regarded as a potential molecular marker in renal cell carcinoma.
Key words: serum microRNAs; renal cell carcinoma; miR-21; molecular markers
对于肾细胞癌早期发现和早期治疗至关重要,按照AJCC肾癌分期,其中Ⅰ期5年生存率约为98%,Ⅲ期5年生存率约为5%[1], 而肾癌早期常没有任何症状,这使早期发现肾癌显得非常困难,组织活检或切片属创伤性方法,在临床上无法实现肿瘤的早期诊断和治疗效果的正确评估。微小RNA(microRNAs,miRNAs)是一类全长约19~25 nt的非编码单链小分子RNA,成熟的miRNA在RISC(RNA-induced silencing complex)引导下通过与mRNA的3′端非翻译区(’-UTR)完全或不完全互补配对,从而影响靶mRNA的翻译,引起翻译后水平调节基因表达作用[2-3]。……
